|
IgG positive
n=32
|
IgG negative
n=14
|
p value
|
Age (years) |
47.5 ± 11.1 |
42.2 ± 13.8 |
0.172 |
Male, n (%) |
23 (71.9) |
9 (64.3) |
0.427 |
Etiology of CKD |
Etiology of CKD |
Etiology of CKD |
Etiology of
CKD |
Diabetes Mellitus, n (%) |
4 (12.5) |
1 (7.1) |
0.364 |
Glomerulonephritis, n (%) |
7 (21.9) |
1 (7.1) |
|
Others, n (%) |
21 (65.6) |
12 (85.7) |
|
Living donor, n (%) |
24 (75.0) |
11 (84.6) |
0.392 |
Transplantation Duration (months) |
108.9 ± 61.9 |
88.0 ± 78.8 |
0.337 |
Comorbidities |
Comorbidities |
Comorbidities |
Comorbidities |
Diabetes, n (%) |
10 (31.3) |
3 (21.4) |
0.381 |
Hypertension, n (%) |
22 (68.8) |
9 (64.3) |
0.511 |
Coronary artery disease, n (%) |
7 (21.9) |
5 (35.7) |
0.264 |
Chronic obstructive pulmonary disease, n (%) |
2 (6.3) |
1 (7.1) |
0.673 |
BMI (kg/m²) |
27.6 ± 4.3 |
26.9 ± 5.1 |
0.529 |
Serum creatinine (mg/dL) |
1.33 (1.03-1.48) |
1.15 (0.87-1.83) |
0.867 |
e-GFR†(ml/min/1.73 m²) |
63.5 ± 19.0 |
68.3 ± 33.6 |
0.537 |
Disease severity index |
Disease severity index |
Disease severity index |
Disease severity index |
Asymptomatic to mild, n (%) |
21 (66.0) |
12 (85.0) |
0.286 |
Severe to critical, n (%) |
11 (34.0) |
2 (15.0) |
|
Days following RT-PCR test |
37.5 (20.5-57.8) |
82.5 (52.3-105.0) |
0.001 |
Lowest white blood cell count, (/mm³) |
4925.7 ± 1748.0 |
4596.8 ±
1667.2 |
0.582 |
Lowest lymphocytes count, (/mm³) |
791.0 ± 603.0 |
665.4 ± 314.7 |
0.875 |
Peak CRP, (mg/dL) |
75.8 ± 66.5 |
74.7 ± 58.0 |
0.813 |
Peak ferritin, (ng/mL) |
625.0 (249.5-1468.3) |
670.1 (236.0-1245.0) |
0.839 |
Fibrinogen, (mg/dL) |
447.8 (4.98-649.8) |
329.1 (4.76-515.5) |
0.439 |
Peak D- Dimer, (µg/mL) |
1.03 (0.36-2.94) |
0.91 (0.66-2.78) |
0.868 |
Peak procalcitonin, (ng/mL) |
1.72 (0.92-127.0) |
92.5 (1.13-191.3) |
0.146 |
Peak uric acid, (mg/dL) |
8.1 ± 2.1 |
7.7 ± 2.3 |
0.622 |
Stopping MPA, n (%) |
17 (53.1) |
7 (50.0) |
0.549 |
Stopping CNI, n (%) |
3 (9.4) |
0 (0.0) |
NA |
Stopping MPA or CNI, n (%) |
18 (56.3) |
7 (50.0) |
0.471 |